eClinic: increasing use of telehealth as a risk reduction strategy during the covid-19 pandemic by Kemp, Michael T et al.
1Kemp MT, et al. Trauma Surg Acute Care Open 2020;5:e000481. doi:10.1136/tsaco-2020-000481
Open access 
eClinic: increasing use of telehealth as a risk 
reduction strategy during the covid-19 pandemic
Michael T Kemp, Aaron M Williams, Hasan B Alam
To cite: 
Kemp MT, Williams AM, 
Alam HB. Trauma Surg Acute 
Care Open 2020;5:e000481.
Department of Surgery, 
University of Michigan, Ann 
Arbor, Michigan, USA
Correspondence to
Dr Hasan B Alam;  alamh@ med. 
umich. edu
Received 1 April 2020
Accepted 2 April 2020
Current opinion
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published 
by BMJ.
AbsTrACT
Prior to the covid-19 pandemic, telehealth was already 
being rapidly adopted nationally by healthcare systems. 
During the covid-19 pandemic, increased use of 
telehealth may be considered as a risk reduction strategy. 
Benefits of this strategy may be conferred to both 
patients and health providers.
TeleheAlTh: pAsT And presenT
Prior to the novel covid-19 pandemic, telehealth 
was being rapidly adopted nationally by healthcare 
systems for the purpose of providing remote care to 
patients.1–3 This pattern was supported by the intent 
to improve hospital efficiency, increase patient and 
provider satisfaction, and improve patient access 
and reduce barriers to medical care.1–4 Our group 
previously has also demonstrated that a surgical 
electronic clinic (eClinic) is a safe, high- quality, 
effective, and feasible mode for providing postop-
erative surgical care.4 These all remain important 
reasons for hospital systems to continue to use 
telehealth care. However, during the covid-19 
pandemic, increased use of telehealth may confer 
additional benefits not frequently recognized and 
warrant further consideration among the medical 
community.5 In this opinion article, we highlight 
the use of telehealth platforms during the covid-19 
pandemic as a worthwhile risk reduction strategy 
for both patients and providers.
reCogniTion of The Covid-19 pAndemiC 
And soCiAl disTAnCing sTrATegies
In February of 2020, the WHO highlighted 
the novel covid-19 as the source of the current 
pandemic.6 After the initial outbreak in Wuhan, 
China, covid-19 has since spread to the USA, which 
is now experiencing a surge in covid-19- confirmed 
cases.6 In response to the rapid expansion of covid-
19, the Center for Disease Control’s (CDC) primary 
modes of disease prevention have been through 
limiting exposure and social distancing.6 Several 
institutions and businesses have since followed these 
recommendations by implementing virtual inter-
actions. Similarly, some universities have imple-
mented online classes. Several major sporting and 
social events across the USA have even been post-
poned or canceled. Unfortunately, due to concerns 
surrounding a lack of appropriate testing and the 
potential for asymptomatic transmission, uninten-
tional exposures may still occur.6 To combat these 
problems, an eClinic platform could be employed 
by healthcare systems to provide excellent clinical 
care of patients while reducing the risk of exposure 
for both patients and healthcare providers.
UndersTAnding eCliniC As A risk 
redUCTion sTrATegy for providers And 
pATienTs
Despite the current concerns surrounding the 
covid-19 pandemic, healthcare workers heroically 
continue to provide care to their patients. As the 
virus continues to spread throughout the USA, 
active healthcare workers will face an increased risk 
of exposure to patients infected with covid-19. It 
is important to recognize that this pandemic is not 
the first time that healthcare workers have risked 
personal exposure to viral illness for patient care. 
For instance, this happens yearly for surgeons, 
nurses, and other critical care providers during the 
influenza season. With this increased risk of expo-
sure, hospital systems often encourage or mandate 
yearly influenza vaccines for employees as a means 
of risk reduction. This pandemic, however, has an 
added layer of complexity as there is unfortunately 
no current covid-19 vaccine that can be provided 
to healthcare workers.6 Further compounded 
by concerns surrounding limited availability of 
personal protective equipment, providers face the 
dilemma of how to continue providing high- quality 
patient care while also reducing the risk of trans-
mission to patients and others.
eClinic use offers the unique potential to allow 
providers to continue providing high- quality care 
and reduce risk of exposure and transmission from 
patient to provider and from patient to patient. 
It even extends to minimize transmission from 
provider to other providers, patients, and even 
their own families. Within the evolving covid-19 
pandemic, increasing use of eClinics for patients 
who are covid-19 confirmed or suspected can be 
life- saving. Not only could this be used to manage 
these patients in the ambulatory setting, but also 
this could help offload the overwhelmed emer-
gency services and first responders who are triaging 
and prioritizing critically ill patients. These eClinic 
strategies are clearly consistent with the CDC’s 
recommendations.
In addition, the benefits of eClinics extend 
beyond covid-19- confirmed or suspected patients. 
Increased eClinic use should also be considered 
for non- covid-19 or asymptomatic patients to 
minimize risk to these patients. Furthermore, it 
should be highly considered for patients suspected 
to be at increased risk of developing severe signs 
and symptoms of covid-19. This includes those 
patients who have substantial comorbidities, live 
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in nursing homes, are immunosuppressed, are aged 65 years 
and older, or are currently pregnant or breast feeding.6 If care 
for these patients can be triaged remotely, this will reduce risk 
exposure while seeking care, particularly at facilities that are 
treating patients with covid-19. These measures also confer 
decreased risk to providers who may unknowingly be exposed 
to patients with covid-19 who are asymptomatic or have not 
been tested. Therefore, this may help decrease the number of 
providers at risk of developing symptoms related to covid-19 
infection.
Lastly, we also think the eClinic platform should be considered 
as a strategy to reintegrate medical providers who are deemed 
too high risk for COVID-19 exposure and are removed from 
direct patient contact. Rather than fully removing these crucial 
providers from the healthcare workforce, restructuring their 
involvement in an eClinic platform can allow them to continue 
to provide critically necessary patient care services without 
conferring risk to themselves or others.
ConClUding ThoUghTs
In conclusion, we believe that increased use of eClinic will 
reduce risk for both providers and patients while also allowing 
continued high- quality care to patients. If adopted, future 
studies should evaluate the impact of these efforts on transmis-
sion outcomes for patients and providers. Such information will 
educate our medical community regarding the efficacy of such 
strategies, even beyond the covid-19 pandemic.
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